Incidental Mutation 'ANU74:Eloc'
ID 262667
Institutional Source Beutler Lab
Gene Symbol Eloc
Ensembl Gene ENSMUSG00000079658
Gene Name elongin C
Synonyms 2610301I15Rik, Tceb1
Accession Numbers
Essential gene? Probably essential (E-score: 0.952) question?
Stock # ANU74
Quality Score 225
Status Not validated
Chromosome 1
Chromosomal Location 16711949-16727266 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 16713574 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Phenylalanine to Leucine at position 115 (F115L)
Ref Sequence ENSEMBL: ENSMUSP00000139480 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000115352] [ENSMUST00000185393] [ENSMUST00000185771] [ENSMUST00000186701] [ENSMUST00000186948] [ENSMUST00000187910] [ENSMUST00000188641]
AlphaFold P83940
Predicted Effect possibly damaging
Transcript: ENSMUST00000115352
AA Change: F93L

PolyPhen 2 Score 0.715 (Sensitivity: 0.86; Specificity: 0.92)
SMART Domains Protein: ENSMUSP00000111009
Gene: ENSMUSG00000079658
AA Change: F93L

DomainStartEndE-ValueType
Skp1 16 112 2.41e-36 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000185393
AA Change: F93L

PolyPhen 2 Score 0.452 (Sensitivity: 0.89; Specificity: 0.90)
SMART Domains Protein: ENSMUSP00000140161
Gene: ENSMUSG00000079658
AA Change: F93L

DomainStartEndE-ValueType
Skp1 16 95 2.6e-22 SMART
Predicted Effect possibly damaging
Transcript: ENSMUST00000185771
AA Change: F93L

PolyPhen 2 Score 0.715 (Sensitivity: 0.86; Specificity: 0.92)
SMART Domains Protein: ENSMUSP00000139675
Gene: ENSMUSG00000079658
AA Change: F93L

DomainStartEndE-ValueType
Skp1 16 112 2.41e-36 SMART
Predicted Effect noncoding transcript
Transcript: ENSMUST00000186541
Predicted Effect probably benign
Transcript: ENSMUST00000186701
SMART Domains Protein: ENSMUSP00000139741
Gene: ENSMUSG00000079658

DomainStartEndE-ValueType
Pfam:Skp1_POZ 17 51 1.1e-14 PFAM
Predicted Effect possibly damaging
Transcript: ENSMUST00000186948
AA Change: F93L

PolyPhen 2 Score 0.715 (Sensitivity: 0.86; Specificity: 0.92)
SMART Domains Protein: ENSMUSP00000140962
Gene: ENSMUSG00000079658
AA Change: F93L

DomainStartEndE-ValueType
Skp1 16 112 2.41e-36 SMART
Predicted Effect possibly damaging
Transcript: ENSMUST00000187910
AA Change: F115L

PolyPhen 2 Score 0.816 (Sensitivity: 0.84; Specificity: 0.93)
SMART Domains Protein: ENSMUSP00000139480
Gene: ENSMUSG00000079658
AA Change: F115L

DomainStartEndE-ValueType
low complexity region 2 27 N/A INTRINSIC
Skp1 38 134 1.2e-38 SMART
Predicted Effect possibly damaging
Transcript: ENSMUST00000188641
AA Change: F93L

PolyPhen 2 Score 0.715 (Sensitivity: 0.86; Specificity: 0.92)
SMART Domains Protein: ENSMUSP00000140422
Gene: ENSMUSG00000079658
AA Change: F93L

DomainStartEndE-ValueType
Skp1 16 112 2.41e-36 SMART
Predicted Effect noncoding transcript
Transcript: ENSMUST00000188987
Predicted Effect noncoding transcript
Transcript: ENSMUST00000191535
Predicted Effect noncoding transcript
Transcript: ENSMUST00000190986
Coding Region Coverage
  • 1x: 99.3%
  • 3x: 98.7%
  • 10x: 97.2%
  • 20x: 95.3%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes the protein elongin C, which is a subunit of the transcription factor B (SIII) complex. The SIII complex is composed of elongins A/A2, B and C. It activates elongation by RNA polymerase II by suppressing transient pausing of the polymerase at many sites within transcription units. Elongin A functions as the transcriptionally active component of the SIII complex, whereas elongins B and C are regulatory subunits. Elongin A2 is specifically expressed in the testis, and capable of forming a stable complex with elongins B and C. The von Hippel-Lindau tumor suppressor protein binds to elongins B and C, and thereby inhibits transcription elongation. Multiple alternatively spliced transcript variants encoding two distinct isoforms have been identified. [provided by RefSeq, Mar 2011]
Allele List at MGI
Other mutations in this stock
Total: 49 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Adgra3 G A 5: 50,118,380 (GRCm39) S1056L probably benign Het
Ankrd26 A T 6: 118,529,736 (GRCm39) D236E probably benign Het
Capn15 C T 17: 26,184,460 (GRCm39) W7* probably null Het
Celsr2 G A 3: 108,319,815 (GRCm39) T999M probably damaging Het
Chrd T A 16: 20,560,069 (GRCm39) M912K possibly damaging Het
Col9a1 A G 1: 24,224,409 (GRCm39) D197G unknown Het
Csf1r A G 18: 61,250,463 (GRCm39) E431G probably benign Het
Fap T C 2: 62,378,113 (GRCm39) D193G probably damaging Het
Fscn2 T C 11: 120,253,162 (GRCm39) Y210H probably damaging Het
Fut9 G C 4: 25,620,802 (GRCm39) T4R probably benign Het
Grb2 A T 11: 115,536,733 (GRCm39) D131E probably benign Het
Hecw2 T C 1: 53,964,853 (GRCm39) T658A probably benign Het
Helz2 T C 2: 180,876,627 (GRCm39) E1289G probably benign Het
Hyou1 A G 9: 44,292,560 (GRCm39) N92D possibly damaging Het
Irf8 A C 8: 121,466,608 (GRCm39) I18L possibly damaging Het
Kif12 GGGGC GGGGCCTCCACCCGGCGGGC 4: 63,089,660 (GRCm39) probably benign Het
Kif12 GC "GCCTCCACCCGGCGGTC,GCC" 4: 63,089,663 (GRCm39) probably null Het
Lamc2 A C 1: 153,007,581 (GRCm39) D864E probably benign Het
Map3k4 A G 17: 12,451,863 (GRCm39) V1475A probably damaging Het
Mapk8ip3 A C 17: 25,119,551 (GRCm39) M1030R possibly damaging Het
Mat1a A G 14: 40,833,099 (GRCm39) D94G probably benign Het
Myh15 T A 16: 48,993,295 (GRCm39) D1643E possibly damaging Het
Myo15b T C 11: 115,769,239 (GRCm39) F55L probably damaging Het
Nhlh2 A T 3: 101,919,970 (GRCm39) M1L probably benign Het
Nup214 T C 2: 31,924,978 (GRCm39) S1836P probably damaging Het
Olr1 G A 6: 129,477,032 (GRCm39) R78C possibly damaging Het
Or5m9 T A 2: 85,877,655 (GRCm39) Y276* probably null Het
Pam16 C A 16: 4,434,497 (GRCm39) V98F probably damaging Het
Pelp1 C T 11: 70,285,913 (GRCm39) V652I probably damaging Het
Pole A G 5: 110,437,236 (GRCm39) H67R probably benign Het
Rbms1 G T 2: 60,628,060 (GRCm39) A60E probably damaging Het
Recql4 A T 15: 76,589,957 (GRCm39) M789K possibly damaging Het
Rrn3 T C 16: 13,629,397 (GRCm39) F571S possibly damaging Het
Ryr3 T C 2: 112,661,575 (GRCm39) probably null Het
Sec61b C A 4: 47,474,922 (GRCm39) N26K possibly damaging Het
Serinc1 T C 10: 57,395,938 (GRCm39) E284G probably benign Het
Slc30a9 G A 5: 67,507,195 (GRCm39) D496N probably damaging Het
Slc44a4 G A 17: 35,140,554 (GRCm39) R249H probably damaging Het
Slc6a13 A C 6: 121,311,835 (GRCm39) D404A probably benign Het
Spata18 A G 5: 73,828,456 (GRCm39) E225G probably damaging Het
Sspo G A 6: 48,437,893 (GRCm39) G1351S probably damaging Het
Tgm3 T C 2: 129,890,310 (GRCm39) V691A probably damaging Het
Tns3 C T 11: 8,442,149 (GRCm39) R738Q probably benign Het
Tyk2 A T 9: 21,027,454 (GRCm39) I506N probably damaging Het
Ube2v1 G A 2: 167,452,264 (GRCm39) T113I probably damaging Het
Vmn1r177 A G 7: 23,565,645 (GRCm39) V77A possibly damaging Het
Vmn2r14 A T 5: 109,366,910 (GRCm39) S437T probably benign Het
Vmn2r78 G C 7: 86,570,273 (GRCm39) V264L possibly damaging Het
Zfp956 T G 6: 47,940,507 (GRCm39) Y289D probably benign Het
Other mutations in Eloc
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01620:Eloc APN 1 16,713,502 (GRCm39) utr 3 prime probably benign
IGL01774:Eloc APN 1 16,716,013 (GRCm39) missense probably benign 0.06
R5393:Eloc UTSW 1 16,718,192 (GRCm39) utr 5 prime probably benign
Predicted Primers PCR Primer
(F):5'- TGCTCGGCAATTAGCTTTACAGCTC -3'
(R):5'- TGCCTCACAAAGTGCCATCCTG -3'

Sequencing Primer
(F):5'- GCTTTACAGCTCAATTTCATACAGG -3'
(R):5'- tcttttcacatcctcttctctcc -3'
Posted On 2015-02-04